Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the ...
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data
Source: eagletribune.com
Stay updated with breaking news from Engineered Long Acting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data